| Generic Name | Brand Name |
|---|---|
| docetaxel | Taxotere |
Docetaxel is an intravenous (IV) medicine that is usually given in a dose based on body surface area. The type and extent of a cancer determines the exact dose and schedule for giving this drug.
Docetaxel damages structures involved in cell division, which stops the growth of cancer cells. It is used to treat breast cancer and non–small cell lung cancer. It may also be used to treat bladder, esophageal, ovarian, prostate, and stomach cancer.
Docetaxel is an effective antitumor medicine. But the type and extent of a cancer determines how effectively this medicine slows or stops the growth of cancer cells in the body.
Serious side effects are rare, but include:
Less serious side effects are more common and may include:
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
Docetaxel should be given only under the supervision of a medical oncologist.
You may not be able to become pregnant or father a child after taking this medicine. Talk with your doctor about fertility before starting treatment.
Docetaxel can cause birth defects. Do not use this medicine if you are pregnant or wish to become pregnant or to father a child while you are taking it.
Do not drink alcohol while you are being treated with docetaxel.
Do not use this medicine if you have:
Complete the new medication information form (PDF)(What is a PDF document?) to help you understand this medication.
Last Revised: May 27, 2010
Author: Healthwise Staff
Medical Review: Anne C. Poinier, MD - Internal Medicine & Michael Seth Rabin, MD - Medical Oncology
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
RT @sanfordtimg: #sanfordresearch's Dr. Amy Elliott is filling @keloland in on the CRCAIH Annual Summit http://t.co/brWO1zbKUd